Shareholding4 Nov 2026, 03:54 pm
Jenburkt Pharma: Counter Cyclical Investment Buys 4,608 Shares
AI Summary
Counter Cyclical Investment Private Limited, acting as a Portfolio Manager, along with its clients, has acquired 4,608 shares of Jenburkt Pharmaceuticals Ltd. This transaction represents a 0.10% increase in their shareholding. Following the purchase, Counter Cyclical Investment and its clients now hold a total of 225,539 shares, amounting to 5.11% of the total equity share capital of Jenburkt Pharmaceuticals.
Key Highlights
- Counter Cyclical Investment acquired 4,608 shares of Jenburkt Pharmaceuticals.
- The acquisition represents a 0.10% increase in shareholding.
- Total holding post-acquisition is 225,539 shares.
- The new shareholding constitutes 5.11% of the company's equity.
- Transaction was conducted via open market purchase.
Price Impact
More from JENBURPH
Quarterly Result1d ago, 6:11 pm
Jenburkt Pharmaceuticals Declares Standalone Unaudited Q2 FY27 Results
Quarterly Result1d ago, 6:00 pm
Jenburkt Q2 FY27: PAT flat YoY at ₹10.2 Cr as margins compress despite 6% revenue growth
Board Meeting29 Oct, 3:36 pm
Jenburkt Pharmaceuticals Board Meeting on Nov 3, 2026